Iaso Ventures
Overview
Iaso Ventures is a venture capital investment firm focused on the healthcare and life sciences sector. Headquartered in Boston, the firm invests in companies developing innovative technologies and solutions that have the potential to deliver transformative impact for patients. The firm actively partners with leading research hospitals, disease foundations, pharma and medtech companies, and other key stakeholders to weave together a unique innovation ecosystem. Empowered by this partner network, Iaso Ventures portfolio companies have pioneered ground-breaking applications in such diverse areas as AI-enabled drug discovery and clinical development, drug design and delivery platforms, first-in-class therapeutics, and digital technologies for full lifecycle support across the entire life sciences value chain. Iaso Ventures invests in game-changing startups that aim to cure disease and improve patient lives. We back data-driven enabling technologies and platforms that support next-generation therapeutic development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aerska | Feb 2026 | Series A | Co-investor |
| Prudentia Sciences | Jan 2026 | Series A | Co-investor |
| Ryght AI | Jun 2025 | Seed | Co-investor |
| Zafrens | Feb 2025 | Series A | Co-investor |
| Prudentia Sciences | Jan 2025 | Seed | Co-investor |
Key People
Wasim Malik
Managing Partner
John Reynders
Venture Partner And Chief Data Scientist
Michael Fenn
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.